About Precision Medicine Group

Precision Medicine Group, founded in 2012 by Mark P. Clein and Ethan D. Leder, is a specialized services company headquartered in Bethesda, Maryland. The company comprises two primary divisions: Precision for Medicine, a global biomarker-driven clinical research organization, and Precision AQ, which offers commercialization services supporting life sciences organizations from product launch through maturity. Precision Medicine Group specializes in advanced lab sciences, translational informatics, payer insights, regulatory affairs, and marketing communications, aiming to assist pharmaceutical and life sciences clients in overcoming product development and commercialization challenges. The company has received multiple awards, including the 2023 CRO Leadership Awards in five categories, including Capabilities, Expertise, Compatibility, Quality, and Reliability, recognizing its performance in the CRO industry. Regarding employment practices, Precision Medicine Group fosters a collaborative, team-oriented culture that emphasizes teamwork, training, development, and building lasting relationships. The company offers competitive benefits for eligible employees, including generous paid time off, medical insurance with health savings or flexible spending accounts, dental and vision insurance, and a 401(k) plan. Precision Medicine Group provides equal employment opportunities, making hiring decisions solely based on qualifications without discrimination based on race, color, age, religion, sex, sexual orientation, gender identity, national origin, disability, or veteran status.